A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection

W Huang, Q Cai, Y Huo, J Tang, Y Chen, Y Fang… - Open life …, 2023 - degruyter.com
Warfarin is an anticoagulant commonly used as an oral drug in preventing and treating
thromboembolic diseases. The international normalized ratio (INR) is a clinical monitoring …

Pharmacogenetic variants influence vitamin K anticoagulant dosing in patients with mechanical prosthetic heart valves

L Koshy, R Vb, MP Ben, P Kishor… - …, 2022 - Taylor & Francis
Background: Vitamin K antagonists (VKAs) are class I oral anticoagulants that are widely
prescribed following surgical heart valve implantation. The objective of this study was to …

Warfarin dose requirement in patients having severe thrombosis or thrombophilia

TA Helin, L Joutsi‐Korhonen… - British Journal of …, 2019 - Wiley Online Library
Aims Warfarin dose requirement varies significantly. We compared the clinically established
doses based on international normalized ratio (INR) among patients with severe thrombosis …

Frequencies of polymorphisms in genes affecting the pharmacokinetics of warfarin in the Zaporizhzhia region

MY Kolesnyk, YM Mykhailovskyi - 2021 - dspace.zsmu.edu.ua
The aim of the study: to establish the frequencies of polymorphisms in VKORC1, CYP2C9
and CYP4F2 genes among residents of the Zaporizhzhia region. Materials and methods. A …

[PDF][PDF] Nghiên cứu tính đa hình gen CYP2C9, VKORC1 và liều thuốc chống đông kháng vitamin K ở bệnh nhân thay van tim cơ học

PT Thùy - 2020 - lib.yhn.edu.vn
Để hoàn thành luận án này, trước hết, tôi xin bày tỏ lòng tri ân sâu sắc tới GS. TS. Tạ Thành
Văn, Chủ tịch Hội đồng Trường, Nguyên Hiệu trưởng, Trưởng Bộ môn Hóa sinh Trường Đại …

Influence of CYP2C9 Polymorphisms on Plasma Concentration of Warfarin and 7-Hydroxy Warfarin in South Indian Patients

DK Kumar, CRS Uppugunduri… - Current Drug …, 2021 - ingentaconnect.com
Background: Warfarin is primarily metabolized by cytochrome P450 2C9 (CYP2C9) enzyme,
which is encoded by the CYP2C9 gene. CYP2C9* 2 and CYP2C9* 3 variants significantly …

Прогнозування безпечності та індивідуалізація антикоагулянтної терапії при фібриляції передсердь з урахуванням особливостей гемостазу та чутливості …

ЯМ Михайловський - 2023 - dspace.zsmu.edu.ua
Дисертація присвячена прогнозуванню безпечності та оптимізації антикоагулянтної
терапії при фібриляції передсердь (ФП) шляхом дослідження клінічних особливостей …

[HTML][HTML] Association between genes polymorphisms in CYP4F2 (rs2108622), VKORC1 (rs9923231, rs2884737), CYP2C9* 2 (rs1799853) for required therapeutic …

S Zahedifar, S Ghadami, M Eslami… - … Science Journal of …, 2023 - tmuj.iautmu.ac.ir
Background: Warfarin is the most commonly prescribed anticoagulant drug for treating
thromboembolic events. There is a variation in dose requirements for each individual due to …

[HTML][HTML] ВКЛАД В ЧАСТОТУ РАЗВИТИЯ КРОВОТЕЧЕНИЙ–НОСИТЕЛЬСТВА ПОЛИМОРФИЗМОВ, ВЛИЯЮЩИХ НА МЕТАБОЛИЗМ ВАРФАРИНА В АСПЕКТЕ …

ММ Маркова, ОС Полунина… - Вестник новых …, 2022 - cyberleninka.ru
Цель исследования–изучить и проанализировать вклад в частоту развития
кровотечений–носительства полиморфизмов, влияющих на метаболизм варфарина–c …

Warfarin dosing prediction algorithm assessments in Asian patients after aortic surgery

W Peng, X Shi, Y Zhang, Y Zhang, J Han, J Yan… - 2022 - researchsquare.com
Background: To evaluate the accuracy and predictive performance of multiple linear
regression algorithms, Gage algorithm and International Warfarin Pharmacogenetics …